MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lipocine (LPCN) Ownership - Who owns Lipocine?
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.12M
P/E Ratio
N/A
Total Cash
17.94M
Projected Growth
N/A
Total Debt
1.48M
Revenue
4.21M
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
3.31
Total Debt/Equity
N/A
Revenue/Share
0.78 USD as % of share price
Fundamentals
LPCN
Capitalization
16.1M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
17.9M
Total Cash/Share
3.31
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.78%
Revenue
4.21M
ROE
N/A
Book Value
17.1M
P/B Ratio
0.94
Cash Flow
N/A
Earnings
-0.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.87K
Current Ratio
12.71
Current Revenue Per Employee
38928.06
Dividends Per Share - Security
N/A
EBITDA
-5.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
-243.06
Revenue To Assets
-21.66
Shares Held By Institutions
2.59M
Shares Outstanding - Current
5.42M
Total Liabilities
1.45M
Total Volume MTD
N/A
Value
1
Gain YTD
-39.029
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com